Sistanizad, 30 patient vitamin D ICU RCT: 64% lower mortality [p=0.004] https://c19p.org/sistanizad
copied to clipboard
High dose vitamin D improves total serum antioxidant capacity and ICU outcome in critically ill patients - a randomized, double-blind clinical trial
et al., European Journal of Integrative Medicine, doi:10.1016/j.eujim.2020.101271
RCT of 30 ventilated ICU patients showing lower mortality with vitamin D treatment, RR 0.36, p = 0.004. Authors do not indicate why the patients were hospitalized or if any of the patients were COVID-19 patients. 300,000 IU intramuscular vitamin D was used.
|
risk of death, 63.5% lower, RR 0.36, p = 0.004, treatment 5 of 16 (31.2%), control 12 of 14 (85.7%), NNT 1.8.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Sistanizad et al., 12/26/2020, Randomized Controlled Trial, Iran, Middle East, peer-reviewed, 8 authors, dosage 300,000IU single dose, intramuscular.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.